Literature DB >> 7986147

Blood transfusions and local tumor recurrence in colorectal cancer. Evidence of a noncausal relationship.

O R Busch1, W C Hop, R L Marquet, J Jeekel.   

Abstract

OBJECTIVE: The authors analyzed the effect of blood transfusions on the pattern of colorectal cancer recurrence.
BACKGROUND: Retrospective studies suggest that blood transfusions are associated with a poor prognosis in patients who undergo operations for colorectal malignancies. In a previously published, randomized trial, it was investigated whether autologous blood transfusions could overcome this putative detrimental effect. However, this did not appear to be the case.
METHODS: In the current study, the authors analyzed the patterns of recurrence in 420 patients who underwent curative operations for colorectal cancer.
RESULTS: Patients who did not require transfusions (N = 143) had significantly better disease-free survival than those who did need transfusions (N = 277); percentages at 4 years were 73% and 59%, respectively (p = 0.001). No difference was found between both groups in comparing cumulative percentages of patients having metastases; percentages at 4 years were 25% in the group that did not undergo transfusion and 27% in the transfused group. The percentage of cases having local recurrence, however, was significantly increased (p = 0.0006) in the transfused group as compared with the group that did not undergo transfusion; percentages at 4 years were 20% and 3%, respectively. The groups of patients receiving only allogeneic, only autologous, or both types of transfusions all had a significantly higher incidence of local recurrence than the patients who did not receive transfusions, but no differences were found between these three groups.
CONCLUSIONS: These findings suggest that the association between blood transfusions and prognosis in colorectal cancer is a result of the circumstances that necessitate transfusions, leading to the development of local recurrences, but not of distant metastases.

Entities:  

Mesh:

Year:  1994        PMID: 7986147      PMCID: PMC1234482          DOI: 10.1097/00000658-199412000-00013

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  17 in total

Review 1.  Transfusion and host defenses against cancer recurrence and infection.

Authors:  N Blumberg; J M Heal
Journal:  Transfusion       Date:  1989 Mar-Apr       Impact factor: 3.157

2.  Large bowel cancer: the effect of perioperative blood transfusion on outcome.

Authors:  S Cheslyn-Curtis; L P Fielding; R Hittinger; J S Fry; R K Phillips
Journal:  Ann R Coll Surg Engl       Date:  1990-01       Impact factor: 1.891

3.  Blood transfusion and recurrence of colorectal cancer: the role of platelet derived growth factors.

Authors:  R J Lawrance; A J Cooper; M Loizidou; P Alexander; I Taylor
Journal:  Br J Surg       Date:  1990-10       Impact factor: 6.939

4.  Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer.

Authors:  S J Cawthorn; D V Parums; N M Gibbs; R P A'Hern; S M Caffarey; C I Broughton; C G Marks
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

5.  Blood transfusions and prognosis in colorectal cancer.

Authors:  O R Busch; W C Hop; M A Hoynck van Papendrecht; R L Marquet; J Jeekel
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245

Review 6.  Perioperative blood transfusion and outcome after resection for colorectal carcinoma.

Authors:  M Chung; O K Steinmetz; P H Gordon
Journal:  Br J Surg       Date:  1993-04       Impact factor: 6.939

7.  Mesorectal excision for rectal cancer.

Authors:  J K MacFarlane; R D Ryall; R J Heald
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

Review 8.  Relationship between blood transfusion and tumour behaviour.

Authors:  D M Francis
Journal:  Br J Surg       Date:  1991-12       Impact factor: 6.939

Review 9.  Results of radical surgery for rectal cancer.

Authors:  R J Heald; N D Karanjia
Journal:  World J Surg       Date:  1992 Sep-Oct       Impact factor: 3.352

10.  The association of perioperative blood transfusion with colorectal cancer recurrence.

Authors:  P I Tartter
Journal:  Ann Surg       Date:  1992-12       Impact factor: 12.969

View more
  26 in total

1.  Research agenda for autologous blood transfusion.

Authors:  H I Atrah
Journal:  Postgrad Med J       Date:  1998-10       Impact factor: 2.401

2.  Peri-operative allogeneic blood transfusion and outcomes after radical cystectomy: a population-based study.

Authors:  D Robert Siemens; Melanie T Jaeger; Xuejiao Wei; Francisco Vera-Badillo; Christopher M Booth
Journal:  World J Urol       Date:  2017-02-17       Impact factor: 4.226

3.  Reported noncausal effect of blood transfusions on colorectal cancer recurrence.

Authors:  A Amato; M Pescatori
Journal:  Ann Surg       Date:  1997-01       Impact factor: 12.969

4.  Blood transfusions and local tumor recurrence in colorectal cancer: evidence of a noncausal relationship.

Authors:  J M Dolezal; R L Cali
Journal:  Ann Surg       Date:  1997-01       Impact factor: 12.969

5.  Peri-operative blood transfusion and operative time are quality indicators for pancreatoduodenectomy.

Authors:  Chad G Ball; Henry A Pitt; Molly E Kilbane; Elijah Dixon; Francis R Sutherland; Keith D Lillemoe
Journal:  HPB (Oxford)       Date:  2010-09       Impact factor: 3.647

Review 6.  Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions.

Authors:  J P Cata; H Wang; V Gottumukkala; J Reuben; D I Sessler
Journal:  Br J Anaesth       Date:  2013-05       Impact factor: 9.166

7.  Does perioperative blood transfusion influence long-term prognosis of gastric cancer?

Authors:  F Sánchez-Bueno; J A García-Marcilla; J M Pérez-Abad; R Vicente; F Aranda; J A Lujan; P Parrilla
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

8.  Impact of blood transfusions on survival and recurrence in colorectal cancer surgery.

Authors:  Igor Gunka; Jan Dostalik; Lubomir Martinek; Petra Gunkova; Miloslav Mazur
Journal:  Indian J Surg       Date:  2012-03-16       Impact factor: 0.656

Review 9.  A risk-benefit assessment of epoetin in the management of anaemia associated with cancer.

Authors:  Y Beguin
Journal:  Drug Saf       Date:  1998-10       Impact factor: 5.606

10.  Perioperative blood transfusion in cancer patients undergoing laparoscopic colorectal resection: risk factors and impact on survival.

Authors:  R Ghinea; R Greenberg; I White; E Sacham-Shmueli; H Mahagna; S Avital
Journal:  Tech Coloproctol       Date:  2013-04-19       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.